Vectus Biosystems Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of VBS?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	1,500	0.00282%
Institutions	638,675	1.2%
Hedge Funds	4,483,896	8.42%
Individual Insiders	8,485,493	15.9%
Private Companies	13,781,584	25.9%
General Public	25,862,164	48.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 19 shareholders own 51.44% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.43%	Kefford Holdings Pty. Ltd.	5,020,000	AU$386.5k	-3.06%	no data
9.17%	Maurie Stang	4,884,952	AU$376.1k	0%	no data
8.42%	Regal Partners Limited	4,483,896	AU$345.3k	0%	0.01%
5.19%	Bernard Stang	2,764,500	AU$212.9k	3.29%	no data
2.82%	Bennelong Resources Pty. Ltd.	1,500,000	AU$115.5k	0%	no data
2.7%	Spinite Pty Ltd	1,435,773	AU$110.6k	0%	no data
2.64%	Grizzly Holdings Pty Ltd	1,407,035	AU$108.3k	0%	no data
2.23%	Towns Corporation Pty Ltd	1,185,000	AU$91.2k	457%	no data
1.88%	Ts Rai 2 Pty Limited	999,999	AU$77.0k	42.9%	no data
1.59%	Exit Out Pty Ltd.	846,538	AU$65.2k	0%	no data
1.41%	Esklaw Pty Ltd	751,549	AU$57.9k	-24.9%	no data
1.2%	Gleneagle Asset Management Limited	638,675	AU$49.2k	-47.2%	0.5%
1.19%	Helensleigh Pty Ltd	632,690	AU$48.7k	0%	no data
0.85%	Mark Kefford	450,000	AU$34.7k	0%	no data
0.65%	Ronald Shnier	345,791	AU$26.6k	0%	no data
0.076%	Susan Pond	40,250	AU$3.1k	0%	no data
0.0028%	Henry Schein, Inc.	1,500	AU$115.6	0%	no data
0.0028%	Ramlist Pty Limited	1,500	AU$115.6	0%	no data
0.0028%	Stangcorp Pty Ltd	1,500	AU$115.6	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/21 00:48
End of Day Share Price	2024/11/29 00:00
Earnings	2024/06/30
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vectus Biosystems Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution